RAINBOW CHILDRENS MED LTD

During the earnings call for Q1 FY 2026-27, management reported a 33% year-on-year revenue growth, driven by contributions from both mature and newly commissioned hospitals. EBITDA grew by 29.9%, reflecting operational discipline and efficiency improvements. Management highlighted the successful rescue of critically ill pediatric patients as a testament to their clinical capabilities. They announced plans to expand bed capacity by 2,500 beds over the next five years, with a focus on entering new markets such as Mumbai and strengthening their presence in Andhra Pradesh. The company maintained a strong balance sheet with cash and equivalents of INR 613 crores. Management expressed confidence in achieving revenue growth of around 20% in the upcoming quarters, despite potential challenges from market dynamics. They emphasized the importance of integrating new acquisitions and enhancing digital capabilities to drive patient engagement and operational efficiency.

Management emphasized strong growth and successful clinical outcomes.